Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sets New 12-Month High - Here's What Happened

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background
Remove Ads

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) shares reached a new 52-week high during mid-day trading on Saturday . The stock traded as high as $20.00 and last traded at $19.50, with a volume of 39684 shares trading hands. The stock had previously closed at $17.41.

Analyst Upgrades and Downgrades

TLX has been the subject of a number of research analyst reports. UBS Group lifted their price target on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research report on Tuesday, November 19th.

Get Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The stock's fifty day moving average price is $16.91.

About Telix Pharmaceuticals Limited American Depositary Shares

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

See Also

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is There Still Money in AI? How to Invest in the Next Big Wave

Is There Still Money in AI? How to Invest in the Next Big Wave

The AI sector has taken a hit, but is the opportunity gone? Shah Gilani breaks down the current state of AI stocks and the next AI company with 10x potential.

Related Videos

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
7 Inflation-Proof Stocks to Protect Your Portfolio

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads